Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.65 |
| ▸ | RAB9A | P51151 | 3/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | CASP3 | P42574 | 1/20 | 0.59 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.59 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.59 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.57 |
| ▸ | DPP4 | P27487 | 1/20 | 0.56 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL658810 | 0.93 | PDPK1 (0.64) | NPC1RAB9ATDP1CASP3SENP8 | |
| SCHEMBL730593 | 0.90 | GSK3B (0.57) | NPC1RAB9AKMT2AMEN1HSD11B1 | |
| SCHEMBL10766281 | 0.89 | TDP1 (0.77) | NPC1RAB9ATDP1CASP3SENP8 | |
| SCHEMBL15524969 | 0.86 | TDP1 (0.77) | NPC1RAB9ATDP1CASP3SENP8 | |
| SCHEMBL28251466 | 0.86 | TDP1 (0.77) | NPC1RAB9ATDP1CASP3SENP8 | |
| SCHEMBL30572 | 0.86 | TDP1 (0.77) | NPC1RAB9ATDP1CASP3SENP8 | |
| Hydrochloric Acid SCHEMBL27556767 | 0.84 | TDP1 (0.74) | NPC1RAB9ATDP1CASP3SENP8 | |
| SCHEMBL7754574 | 0.83 | NPC1 (0.67) | NPC1RAB9ATDP1CASP3SENP8 | |
| SCHEMBL4217497 | 0.83 | DPP4 (0.77) | NPC1RAB9ATDP1CASP3SENP8 | |
| SCHEMBL8478411 | 0.82 | DPP4 (0.66) | NPC1RAB9ATDP1CASP3SENP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1204636-B1 | 3-OXOPROPANE-1-SULPHONIC ACIDS AND SULPHONATES | DSM IP ASSETS BV (NL) | 2004-10-27 | — | — | EP | claimed |
| CN-111499503-B | Method for synthesizing alpha-alkylated ketone in water | 南京理工大学 | 2022-04-08 | — | — | CN | disclosed |
| CN-111499503-A | Method for synthesizing α -alkylated ketone in water | 南京理工大学 | 2020-08-07 | — | — | CN | disclosed |
| CN-106478325-B | A method of synthesis alpha-alkyl ketone | 南京理工大学 | 2019-06-25 | — | — | CN | disclosed |
| CN-106478395-B | A kind of method of iridium catalyzed synthesizing alpha-alkyl ketone | 南京理工大学 | 2019-06-25 | — | — | CN | disclosed |
| CN-105439787-B | Method for synthesizing α -alkyl ketone | 南京理工大学 | 2018-02-13 | — | — | CN | disclosed |
| CN-106478395-A | A kind of method of iridium catalyzed synthesizing alpha-alkyl ketone | 南京理工大学 | 2017-03-08 | — | — | CN | disclosed |
| CN-106478325-A | A kind of method of synthesis alpha-alkyl ketone | 南京理工大学 | 2017-03-08 | — | — | CN | disclosed |
| CN-104557500-B | A kind of method of synthetic alpha-alkyl ketone | NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2016-05-18 | — | — | CN | disclosed |
| CN-105439787-A | Method for synthesizing alpha-alkyl ketone | UNIV NANJING SCIENCE & TECH | 2016-03-30 | — | — | CN | disclosed |
| EP-2308848-A1 | Quinoline-derived amide modulators of vanilloid VR1 receptor | Janssen Pharmaceutica NV (BE) | 2011-04-13 | — | — | EP | disclosed |
| US-20080300236-A1 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | CODD ELLEN | 2008-12-04 | — | — | US | disclosed |
| US-20080300236-A1 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | CODD ELLEN | 2008-12-04 | — | — | US | disclosed |
| US-20080300236-A1 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | CODD ELLEN | 2008-12-04 | — | — | US | disclosed |
| EP-1603883-A2 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-12-14 | — | — | EP | disclosed |
| US-20050272036-A1 | Ketones | ASTRAZENECA AB (SE) | 2005-12-08 | — | — | US | disclosed |
| EP-1549600-A1 | KETONES | AstraZeneca AB (SE) | 2005-07-06 | — | — | EP | disclosed |
| US-20040192728-A1 | Quinoline-derived amide modulators of vanilloid VR1 receptor | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-09-30 | — | — | US | disclosed |
| WO-2004069792-A2 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (US) | 2004-08-19 | — | — | WO | disclosed |
| WO-2004011410-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2004-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192728-A1 | Quinoline-derived amide modulators of vanilloid VR1 receptor | TRPV1, OPRL1, TRPV2 | NPC1 1518/4885RAB9A 2453/4885TDP1 4042/4885 |
| US-20080300236-A1 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | TRPV1, OPRL1, TRPV2 | NPC1 1518/4885RAB9A 2453/4885TDP1 4042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.